[
    [
        {
            "time": "2018-03-19",
            "original_text": "平安研报20180319",
            "features": {
                "keywords": [
                    "医药股",
                    "基金经理",
                    "逻辑",
                    "医院终端用药结构变化",
                    "投资机会"
                ],
                "sentiment_score": 0.75,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "生物"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "平安研报20180319",
                "Correlation": 6,
                "Sentiment": 5,
                "Importance": 5,
                "Impact": 4,
                "Duration": 5,
                "Entity_Density": 3,
                "Market_Scope": 4,
                "Time_Proximity": 3,
                "Headline_Structure": 4,
                "Source_Recency": 2
            }
        },
        {
            "time": "2018-03-19",
            "original_text": "[强于大市评级]医药生物行业专题研究：机构改革组建医药三大部门 监管开启新篇章",
            "features": {
                "keywords": [
                    "医药生物",
                    "机构改革",
                    "监管",
                    "新篇章"
                ],
                "sentiment_score": 0.8,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "生物"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "[强于大市评级]医药生物行业专题研究：机构改革组建医药三大部门 监管开启新篇章",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 9,
                "Impact": 8,
                "Duration": 8,
                "Entity_Density": 6,
                "Market_Scope": 9,
                "Time_Proximity": 5,
                "Headline_Structure": 8,
                "Source_Recency": 3
            }
        },
        {
            "time": "2018-03-19",
            "original_text": "[推荐评级]医药行业周报：医改新猜想 行业新机会",
            "features": {
                "keywords": [
                    "医药",
                    "医改",
                    "新机会"
                ],
                "sentiment_score": 0.85,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "[推荐评级]医药行业周报：医改新猜想 行业新机会",
                "Correlation": 7,
                "Sentiment": 6,
                "Importance": 6,
                "Impact": 5,
                "Duration": 5,
                "Entity_Density": 5,
                "Market_Scope": 7,
                "Time_Proximity": 5,
                "Headline_Structure": 7,
                "Source_Recency": 4
            }
        },
        {
            "time": "2018-03-19",
            "original_text": "[强于大市评级]医药生物行业研究周报：医药部委体系调整 改革箭在弦上",
            "features": {
                "keywords": [
                    "医药生物",
                    "部委体系调整",
                    "改革"
                ],
                "sentiment_score": 0.8,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "生物"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "[强于大市评级]医药生物行业研究周报：医药部委体系调整 改革箭在弦上",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 6,
                "Market_Scope": 8,
                "Time_Proximity": 5,
                "Headline_Structure": 8,
                "Source_Recency": 3
            }
        },
        {
            "time": "2018-03-19",
            "original_text": "[看好评级]PHARMACEUTICAL: PROMISING INVESTMENT THEMES IN PHARMACEUTICAL INDUSTRY：DRUG PRODUCERS CONSUMP.",
            "features": {
                "keywords": [
                    "医药",
                    "投资主题",
                    "药品生产商"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "[看好评级]PHARMACEUTICAL: PROMISING INVESTMENT THEMES IN PHARMACEUTICAL INDUSTRY：DRUG PRODUCERS CONSUMP.",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 5,
                "Market_Scope": 8,
                "Time_Proximity": 4,
                "Headline_Structure": 7,
                "Source_Recency": 3
            }
        }
    ]
]